The 20 Best HER-2 Positive Breast Cancer Doctors Near Me in Burlington, MA

Elizabeth Mittendorf is a Surgical Oncologist practicing medicine in Boston, Massachusetts. Dr. Mittendorf is rated as an Elite provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Lymphadenectomy. Dr. Mittendorf is board certified in American Board Of Surgery.

Dr. Tolaney is Chief of the Division of Breast Oncology at Dana-Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School.  She is a breast medical oncologist whose research focuses on the development of novel therapies in the treatment of breast cancer.  She has been instrumental in developing several treatment approaches for breast cancer, including approaches focused on tailoring therapy for early stage HER2+ disease, use of cdk 4/6 inhibitors, antibody drug conjugates, and immunotherapy.She is a member of the National Cancer Institute Breast Cancer Steering Committee and is Vice Chair for Late-Stage Development in Breast Cancer in the Alliance for Clinical Trials in Oncology. Her research has been funded by the Breast Cancer Research Foundation and Susan G. Komen. She currently chairs multiple phase 3 trials in breast cancer and serves on several steering committees for practice-changing trials.  Her work has been published in journals such as the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, and others. She received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships in hematology and medical oncology at Dana-Farber Cancer Institute. She obtained a Masters in Public Health from the Harvard School of Public Health in 2007. In 2008, she joined the staff of Dana-Farber Cancer Institute and Brigham and Women's Hospital. Dr. Tolaney is rated as an Elite provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer. Dr. Tolaney is board certified in Medical Oncology.

Dr. Lin is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer, including a particular focus on the challenge of breast cancer brain metastases. She has led multiple clinical trials which have led to new treatment options for patients with breast cancer that has metastasized to the brain. Dr. Lin received her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women's Hospital and went on to complete fellowships in medical oncology and hematology at Dana-Farber. In 2005, she joined the staff of Brigham and Women's and Dana-Farber, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. Dr. Lin is rated as an Elite provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Brain Tumor, and Inflammatory Breast Cancer. Dr. Lin is board certified in Medical Oncology.

Dr. Waks received her undergraduate degree from Princeton University in 2006 and her MD degree from Harvard Medical School in 2011. She completed residency training in internal medicine at Brigham and Women's Hospital, where she subsequently served an additional year as a Chief Resident in Internal Medicine. She completed fellowship training in medical oncology at Dana-Farber/Partners CancerCare, then joined the staff of the Breast Oncology Center at Dana-Farber Cancer Institute. Dr. Waks is rated as an Elite provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Waks is board certified in Internal Medicine and Medical Oncology.

Saritha Bolla is an Internal Medicine specialist and an Oncologist practicing medicine in Winchester, Massachusetts. Dr. Bolla is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Angiosarcoma, and Breast Cancer. Dr. Bolla is board certified in American Board Of Internal Medicine.

Beverly Moy is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Moy is rated as an Elite provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Tissue Biopsy.

Nadine Tung is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Tung is rated as a Distinguished provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Ovarian Cancer, BRCA Positive Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT). Dr. Tung is board certified in American Board Of Internal Medicine.

Dr. Sammons is a medical oncologist specializing in the care of patients with all stages of breast cancer. Her research focuses upon improving the outcomes of people living with metastatic breast cancer. She has led multiple clinical trials which have led to new treatment options for patients with metastatic breast cancer. She also has expertise in the treatment of brain metastases. Dr. Sammons received her MD from Sidney Kimmel Medical College in Philadelphia, PA in 2012. She completed her residency in internal medicine at University of Maryland and went on to complete fellowship in medical oncology and hematology at Duke University. In 2018, she joined the staff of Duke Cancer Institute and ultimately served as Associate Director of Breast Cancer Research. She joined Brigham and Women's and Dana-Farber in 2022, where she is a medical oncologist and clinical investigator in the Breast Oncology Center. She serves as Associate Director of the Metastatic Breast Cancer Program. Dr. Sammons is rated as a Distinguished provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, PIK3CA-Related Overgrowth Spectrum, and Paget Disease of the Breast. Dr. Sammons is board certified in Internal Medicine and Medical Oncology.

Dr. Partridge received her MD from Cornell University Medical College in 1995. She completed her residency in internal medicine at the Hospital of the University of Pennsylvania and went on to complete fellowships in medical oncology and hematology at DFCI, MGH and BWH. She also received an MPH from Harvard School of Public Health. She is a medical oncologist who cares for adults with breast cancer, with a particular focus on the unique needs of young patients with breast cancer. She also leads efforts to optimize cancer survivorship care and research at DFCI. She completed fellowships in Medical Oncology and Hematology at DFCI, Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Partridge is rated as a Distinguished provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, BRCA Positive Breast Cancer, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Partridge is board certified in Medical Oncology.

Etin-osa Osa is a Radiation Oncologist practicing medicine in Burlington, Massachusetts. She has been practicing medicine for over 17 years. Dr. Osa is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Pleuropulmonary Blastoma, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET).

Christopher Wright is a Radiation Oncologist practicing medicine in Burlington, Massachusetts. Dr. Wright is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Breast Cancer, and Pleuropulmonary Blastoma.

Howard Hsu is a Radiation Oncologist practicing medicine in Burlington, Massachusetts. Dr. Hsu is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Lung Cancer, and Pleuropulmonary Blastoma.

Asa Nixon is a Radiation Oncologist practicing medicine in Burlington, Massachusetts. Dr. Nixon is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Large-Cell Lung Carcinoma.

Naomi Jiang is a Radiation Oncologist practicing medicine in Burlington, Massachusetts. Dr. Jiang is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Marginal Zone Lymphoma (MZL), Prostate Cancer, Familial Prostate Cancer, and Pleuropulmonary Blastoma.

Klaudia Hunter is a Radiation Oncologist practicing medicine in Burlington, Massachusetts. Dr. Hunter is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 45 other conditions, according to our data. Her clinical expertise encompasses Intraductal Papilloma, Laryngeal Cancer, Lung Cancer, and Pleuropulmonary Blastoma.

Corrine Zarwan is an Oncologist practicing medicine in Burlington, Massachusetts. Dr. Zarwan is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Endometrial Cancer, Paget Disease of the Breast, and Ovarian Cancer.

Laura Spring is an Oncologist practicing medicine in Danvers, Massachusetts. Dr. Spring is rated as a Distinguished provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Paget Disease of the Breast, and Bone Marrow Transplant. Dr. Spring is board certified in Medical Oncology.

Violeta Ristic is a primary care provider, practicing in Internal Medicine in Burlington, Massachusetts. Dr. Ristic is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Osteoporosis, Postmenopausal Osteoporosis, and Chronic Cough.

Victoria Scanlan is a primary care provider, practicing in Internal Medicine in Burlington, Massachusetts. Dr. Scanlan is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Obesity, Heart Failure with Preserved Ejection Fraction (HFpEF), Melorheostosis with Osteopoikilosis, and Melorheostosis.

Lyubov Girshovich is a Radiation Oncologist practicing medicine in Burlington, Massachusetts. Dr. Girshovich is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Breast Cancer, Intraductal Papilloma, HER-2 Positive Breast Cancer, and Endometrial Cancer.